{Reference Type}: Journal Article
{Title}: Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age.
{Author}: Tanem KE;Wilberg P;Diep PP;Ruud E;Skaare AB;Brinch L;Herlofson BB;
{Journal}: Support Care Cancer
{Volume}: 30
{Issue}: 5
{Year}: May 2022
{Factor}: 3.359
{DOI}: 10.1007/s00520-022-06836-7
{Abstract}: <B>OBJECTIVE: </B>Long-term survivors (LTSs) of allogeneic hematopoietic stem cell transplantation (allo-HCT) may experience oral long-term effects like chronic graft-versus-host disease (oral cGVHD). The aim of this study was to investigate oral cGVHD in patients treated at a young age (< 30 years) more than 5 years after allo-HCT without total body irradiation (TBI).<BR><B>METHODS: </B>All 94 participants went through a semi-structured interview, and an oral examination. Diagnosis of oral cGVHD was based on the "National Institutes of Health (NIH) cGVHD diagnosis and staging consensus criteria" from 2014.<BR><B>RESULTS: </B>Mean age at transplantation was 17.5 years (range 0.4-29.9 years), and mean time since transplantation was 16.7 years (range 6-26 years). Oral cGVHD was diagnosed in 26 (28%) of 94 LTSs. Of which 20 (21.5%) showed lichen planus-like (LPL) changes, and additionally six (6.5%) also fulfilled the diagnostic criteria of oral cGVHD since they had one or more distinctive signs and symptoms of oral cGVHD combined with definite cGVHD in another organ. No LTSs reported oral cGVHD (NIH) grade 3. There was a significant association between cGVHD in the oral cavity and cGVHD in another organ (77% vs 29%, p < 0.001). Out of 72 LTSs, who answered the questions regarding taste disturbances, 16 (22%) reported dysgeusia. No LTSs developed secondary malignancies in the oral cavity during follow-up time.<BR><B>CONCLUSIONS: </B>Oral long-term effects, such as oral cGVHD, may persist for many years after allo-HCT without TBI-conditioning in patients treated at a young age.